JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Setting

Order Through VWR & Receive a FREE Sample

Support: [email protected]

Track Your Order

Home
Search results for: 'abt 263'

Search results for: 'abt 263'

B7737 ABT

Summary: Cytochrome P450 inhibitor

≥12.93 mg/mL
B5298 ABT 702 dihydrochloride

Target: Adenosine Kinases

Summary: Adenosine kinase inhibitor

insoluble in H2O; ≥107.2 mg/mL
B6981 ABT 724 trihydrochloride

Summary: Dopamine D4 receptor agonist,potent and selective

<40.27 mg/mL
A3007 ABT-263 (Navitoclax)
57 Citation

Target: Bcl-2|Bcl-w

Summary: Bcl-2 family inhibitor

≥48.73 mg/mL
A8193 ABT-737
34 Citation

Summary: BCL-2 protein inhibitor

≥40.67 mg/mL
A8194 ABT-199
30 Citation

Target: Bcl-2

Summary: Bcl-2 inhibitor,potent and selective

≥43.42 mg/mL
A1493 ABT-751 (E7010)
1 Citation

Target: Microtubules/Tubulins

Summary: Inhibitor of microtubule polymerization,antimitotic

insoluble in H2O; ≥18.55 mg/mL
A2949 Linifanib (ABT-869)

Target: VEGFR|PDGFR

Summary: VEGFR/PDGFR inhibitor

insoluble in H2O; insoluble in EtOH; ≥18.75 mg/mL
A8439 GSK1292263

Summary: Novel GPR119 agonist

≥21.1 mg/mL
B4786 Zotarolimus(ABT-578)

Summary: anti-proliferative drug used exclusively in coronary drug eluting stent

insoluble in EtOH; ≥24.75 mg/mL